Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

4.44
Delayed Data
As of Apr 21
 +0.11 / +2.54%
Today’s Change
1.65
Today|||52-Week Range
4.69
+77.60%
Year-to-Date

Today’s Trading

Previous close4.33
Today’s open4.36
Day’s range4.22 - 4.50
Volume327,233
Average volume (3 months)218,332
Market cap$88.5M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+60.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book12.86

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp-0.15-13.55%
BDSIBioDelivery Sciences...-0.05-3.03%
CTRVContraVir Pharmaceut...-0.09-6.00%
AFMDAffimed NV-0.17-7.78%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 18, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Chief Operating Officer
Clayton D. Edwards
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs